Our research strategy
Many of the children that pass through Great Ormond Street Hospital (GOSH) have rare and complex conditions that are life-limiting or life-threatening. There is an urgent need to improve the outlook for these children with new solutions and treatment approaches.
We will support research that focuses on taking discoveries from the lab bench to the patients' bedside – this is known as translational research. We will support the delivery of personalised medicine – being able to tailor treatment to each child based on the genetic characteristics of their condition. Our direct research commitments over this period are likely to exceed £50 million.
We want to see an overall improvement in survival rates and quality of life for children with rare and complex conditions.
Much of our funding will go towards six priority areas that represent the strengths of the hospital and the UCL Great Ormond Street Institute of Child Health (ICH), and the particular opportunities that the demographic of the patients that come to GOSH provide. They are: